Cortez Masto Joins Bipartisan Bill to Cap the Cost of Insulin at $35 Per Month

Washington, D.C. - U.S. Senator Catherine Cortez Masto (D-Nev.) joined bipartisan legislation led by Senators Jeanne Shaheen (D-N.H.), Susan Collins (R-Maine), Raphael Warnock (D-Ga.), and John Kennedy (R-La.) to lower the cost of insulin. The Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act would cap the cost of insulin at $35 per month for Americans on private and employer insurance and create a pilot program to provide insulin at the same cost to Americans without insurance.

"For Nevadans with diabetes, insulin isn't optional - it's a necessary medication that they need to take every day," said Senator Cortez Masto. "With prices for everything from food to gas on the rise, Americans need Congress to act now to end Big Pharma's price gouging. We already capped the cost of insulin for seniors, and I'm proud to stand with my colleagues on both sides of the aisle to bring down the cost for all Americans."

Specifically, the INSULIN Act would:

• Limit out-of-pocket costs for patients with diabetes by ensuring that group and individual market health plans must waive any deductible and limit cost-sharing to more than $35 or 25 percent of list price per month for at least one insulin of each type and dosage form;
• Mandate pharmacy benefit managers pass through 100 percent of insulin rebates and other discounts received from manufacturers to plan sponsors, reducing perverse incentives in the insulin market that encourage high list prices; and
• Create a pilot grant program to implement programs to provide uninsured patients with insulin at $35 per month.

Throughout her career, Senator Cortez Masto has consistently fought to bring down the cost of prescription medications and lower Americans' health care costs. She has worked to enable Medicare to negotiate the price of more drugs more quickly. Cortez Masto introduced legislation to reverse Republicans' policies in the One Big Beautiful Bill Act (OBBBA) that block Medicare from negotiating the price of blockbuster drugs and pressed Secretary Robert F. Kennedy Jr. on his support for the OBBBA despite its elimination of provisions to lower prescription drug prices.

###